Danazol for Henoch-Schonlein Purpura

In: Annals of Internal Medicine · 1993 · vol. 118(10) , pp. 827 · doi:10.7326/0003-4819-118-10-199305150-00021 · PMID:8470863 · W2043119229
letter OA: closed CC0 ⤵ 2 in-corpus citations
View on OpenAlex View on PubMed View at publisher
AI-generated summary by gemini-2.5-flash-lite, 2026-06-09

This report describes the successful treatment of a young man with Henoch-Schonlein purpura, refractory to prednisone, using danazol.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Letters15 May 1993Danazol for Henoch-Schonlein PurpuraYoung J. Lee, MD, Lawrence L. Horstman, MD, and Yeon S. Ahn, MDYoung J. Lee, MDSearch for more papers by this author, Lawrence L. Horstman, MDSearch for more papers by this author, and Yeon S. Ahn, MDSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-118-10-199305150-00021 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:Henoch-Schonlein purpura is a form of generalized hypersensitivity vasculitis involving the skin, joints, kidneys, and gastrointestinal tract. Corticosteroids have been the mainstay of therapy [1]. We report the successful use of danazol in a young man with classic recurring Henoch-Schonlein purpura refractory to low-dose prednisone therapy [2].A 22-year old white man in good health developed an upper respiratory infection in November 1988. A few days later, palpable small spots appeared over both malleoli and quickly spread to lower extremities and genitals. There were associated myalgias, arthralgias, and swelling of wrist and ankle joints, followed by lower ...References1. Gotlieb A. Allergic purpura. In: William W, ed. Hematology. Fourth edition. New York: McGraw-Hill; 1990:1443. Google Scholar2. Lee Y, Harrington T, Ahn YS. Danazol: a new therapeutic option for Henoch-Schonlein Purpura. Clin Res. 1991; 39:461A. Google Scholar3. Tomino Y, Sakai H, Hanzawa S, Ohno J, Kitajima T, Sakai O. Clinical effect of danazol in patients with IgA nephropathy. Jpn J Med. 1987; 26:162-6. Google Scholar4. Ahn YS. Efficacy of danazol in hematologic disorders. Acta Haematol. 1990; 84:122-9. Google Scholar5. Madanes AE, Farber M. Danazol. Ann Intern Med. 1982; 96:625-30. Google Scholar Author, Article, and Disclosure InformationAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByDanazol – możliwości wykorzystania w leczeniu chorób hematologicznychDanazol induces prolonged survival of fully allogeneic cardiac grafts and maintains the generation of regulatory CD4+ cells in miceChapter 24 Danazol TherapyApport de la tomodensitométrie abdominopelvienne dans le purpura rhumatoïde de l’adulteSch??nlein-Henoch Purpura in Children and AdultsAngeborene und erworbene vaskuläre hämorrhagische DiathesenPurpura rhumatoïde de l'adulte. À propos de 40 observationsIgA multiple myeloma presenting as Henoch-Schönlein purpura/polyarteritis nodosa overlap syndromeAngeborene und erworbene vaskuläre hämorrhagische Diathesen 15 May 1993Volume 118, Issue 10Page: 827KeywordsInflammationKidneysMyalgiaNauseaProteinuriaRed blood cellsUpper respiratory tract infectionsVasculitisVomitingWeight gain Issue Published: 15 May 1993 CopyrightCopyright © 1993 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (2)

Cited by (2)

Source provenance

openalex
last seen: 2026-05-10T11:49:35.927801+00:00
unpaywall
last seen: 2026-09-02T07:26:43.000666+00:00
License: CC0 · commercial use OK